These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pharmacoeconomic series: Part I. Pharmacoeconomics and the evaluation of drugs and services. McGhan WF Hosp Formul; 1993 Apr; 28(4):365-6, 371-3, 377-8. PubMed ID: 10125323 [TBL] [Abstract][Full Text] [Related]
6. Achieving provider support of pharmacy benefit design. Navarro RP Med Interface; 1995 Aug; 8(8):80-1, 84. PubMed ID: 10144776 [No Abstract] [Full Text] [Related]
7. Cost containment measures in hospital pharmacy: a bibliography. Treleaven S; Einarson TR Can J Hosp Pharm; 1990 Feb; 43(1):17-25. PubMed ID: 10106452 [TBL] [Abstract][Full Text] [Related]
8. A proposed model for conducting institutional-specific cost-effectiveness analysis: a case study of lipid-lowering agents. Hakim Z; Pierson JF; Pathak DS Pharm Pract Manag Q; 1996 Apr; 16(1):79-97. PubMed ID: 10157744 [No Abstract] [Full Text] [Related]
9. Cost effectiveness: pharmacy systems. Bishop SA Ohio State Med J; 1979 May; 75(5):287-9. PubMed ID: 111189 [No Abstract] [Full Text] [Related]
10. Cost-benefit and cost-effectiveness: methodologies for evaluating innovative pharmaceutical services. McGhan WF; Rowland CR; Bootman JL Am J Hosp Pharm; 1978 Feb; 35(2):133-40. PubMed ID: 415603 [TBL] [Abstract][Full Text] [Related]
11. Pharmacoeconomics: therapeutic and economic considerations in treating the critically ill patient. Crane VS DICP; 1990 Nov; 24(11 Suppl):S24-7. PubMed ID: 2125394 [TBL] [Abstract][Full Text] [Related]
12. The 1982 Hoechst Lecture: "Cost effectiveness--the emerging 'bottom line' for pharmacy?!". Marshman JA Can J Hosp Pharm; 1982; 35(2):39-41. PubMed ID: 10309676 [TBL] [Abstract][Full Text] [Related]
13. Cost-benefit of a clinical services integrated with a decentralized unit dose system. Warrian K; Irvine-Meek J Can J Hosp Pharm; 1988 Jun; 41(3):109-12. PubMed ID: 10312603 [TBL] [Abstract][Full Text] [Related]
14. An assessment of the impact and value of clinical pharmacy services. Cohen MR; Turco SJ; Weltmann AJ Hosp Pharm; 1977 Jan; 12(1):9-10, 12-4, 19-20. PubMed ID: 10305424 [No Abstract] [Full Text] [Related]
15. Prospective-pricing strategies for hospital and departmental effectiveness: the administrator's response. Van Etten P Am J Hosp Pharm; 1985 Oct; 42(10):2153-8. PubMed ID: 3933334 [TBL] [Abstract][Full Text] [Related]
16. Determining the differences among cost savings, cost avoidance, and cost reduction. Howard KB; Pathak DS Pharm Pract Manag Q; 1999 Oct; 19(3):1-7. PubMed ID: 10747680 [TBL] [Abstract][Full Text] [Related]